Heart in Diabetes conference will spotlight latest research in cardiometabolic care
Click Here to Manage Email Alerts
Key takeaways:
- The Heart in Diabetes conference will host its seventh annual meeting Friday to Sunday in Philadelphia.
- The conference spotlights the latest clinical research that affects cardiometabolic care.
Leading experts from cardiorenal metabolic specialties will present the latest research with clinical implications for diabetes, CVD and kidney disease, with a new format this year designed to drive multispecialty discussions.
The seventh annual Heart in Diabetes CME Conference, described as where the heart, kidney and diabetes meet in clinical practice, will take place at a new location this year, Friday through Sunday at the Hilton Philadelphia at Penn’s Landing hotel. The 3-day conference will be a live, in-person conference followed by 90 days of access to all meeting materials on demand. The conference will offer 27 CME/maintenance of certification (MOC) credits.
“From its inception, the Heart in Diabetes conference was developed as a combination of cardiology, endocrinology and nephrology,” Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, and co-chair of the Heart in Diabetes conference, told Healio. “It is unique in addressing diabetes/cardiorenal/metabolic issues from every direction, not just from one point of view. Here, you have cardiologists, endocrinologists and nephrologists discussing the different aspects of cardiorenal metabolic disease. The patient does not come just for heart disease or kidney disease or diabetes. Many times, the patient has all of those. We are all going to be faced with these patients.”
This year’s conference will also present some topics in a novel way, allowing for more group discussion after short presentations, Handelsman said.
“Rather than traditional sessions, with two, three or more speakers giving 20-minute lectures on specific topics, we are offering a new format,” Handelsman said during an interview. “We will now offer some panel-based sessions. For these, a speaker will give a 5-minute talk on a topic and then all the panelists, including the session chairs, will discuss it together. The idea is to take issues that may be controversial or where there may be uncertainty and get more into the relevance and implications of practice. This is an innovative way to address these topics from different specialties, whether that may be adult endocrinology, pediatric endocrinology, cardiology or epidemiology.”
Highlights of this year’s conference include the following (all sessions are Eastern time):
- On Friday at 8:15 a.m., the session Heart Disease in Women will include presentations on microvascular disease and small-vessel disease with Annabelle S. Volgman, MD, menopause and diabetes with Healio | Cardiology Today Editorial Board Member Erin D. Michos, MD, MHS, and pregnancy and HF risk with Neha J. Pagidipati, MD, MPH.
- A session on Enigmatic Cardiometabolic Conditions, beginning Friday at 3:10 p.m., will feature presentations on controversies in defining prediabetes with Elizabeth Selvin, PhD, MPH, and the unexplained CV risks with Ralph A. DeFronzo, MD.
- A joint symposium with the journal Circulation will include presentations on the effects of long-term metformin and lifestyle interventions with Dana Dabelea, MD, PhD, empagliflozin and left ventricular remodeling in people without diabetes with Subodh Verma, MD, PhD, and preventing the long-term consequences of type 2 diabetes with Hertzel C. Gerstein, MD.
- The 2023 Luminary in Cardiometabolic Medicine Award will be presented Saturday at 3:05 p.m. to Healio | Cardiology Today Editorial Board Member George L. Bakris, MD, followed by a lecture on the evolution of renoprotective therapies in diabetes.
- Stroke in cardiometabolic conditions and diabetes, beginning Sunday at 9:05 a.m., will include sessions on the intersection of diabetes, heart health and navigating the penumbra with Robert J. Chilton, DO, and stroke prevention and anticoagulation with Gabriel P. Steg, MD.
- State-of-the-art CVD in Diabetes, beginning at 2:50 p.m. Sunday, will include sessions on the role of glycemic control in CVD in type 2 diabetes with Robert H. Eckel, MD, atherosclerotic plaque and stenosis in patients with and without diabetes with Rebecca A. Jonas, MD, and the role of thrombosis prophylaxis in patients with diabetes with Peter J. Grant, MD.
“Nothing here is rehashed; it is not another lecture that you listened to in the previous meeting. All of the content is developed specifically for this meeting,” Handelsman said. “Our speakers are very well versed in the cardiometabolic arena, many speaking across disciplines. They feel this is their home to really give their expertise. This is the one meeting that looks at these links and highlights how medicine should move forward.”
The Cardiology Today, Endocrine Today and Healio staff will provide live coverage from the Heart in Diabetes CME Conference, including reports on the sessions and debates, video interviews and much more, which can be seen at Healio.com/HeartinDiabetes. For more information on the conference, visit www.heartindiabetes.com.
For more information:
Registration is available at heartindiabetes.com/registration.
Collapse
Healio Interviews
Click Here to Manage Email Alerts